TMO

#69
Thermo Fisher Scientific, Inc.
510.71 USD
+2.95%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
510.07
511.08
1年のレンジ
385.46
643.99
1日の変化
+2.95%
月次変化
+8.57%
6か月変化
-2.17%
1年の変化
+14.12%
以前の終値
496.09
始値
510.64
Bid
Ask
安値
510.07
High
511.08
ボリューム
414
チャート全体を表示

Financials

概要 明細書 統計 配当金
期次 年次
  • Market Capitalization 189.72 B
  • Employee 125 K
  • Founded N/A
  • CEO Marc N. Casper
  • Website www.thermofisher.com
  • Headquarter Delaware, United States
  • FIGI BBG000BVDLH9
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
32.66
売上高対価格比率
4.92
1株当たり配当金
1.72
配当利回り（％）
0.3

Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation, Alfa Aesar, Affymetrix, FEI Company, BD Advanced Bioprocessing, and PPD. It ranked 104th on the Fortune 500 list based on its 2024 annual revenue of $42.879 billion. Thermo Fisher announced a $2 billion investment over four years in the U.S., including $1.5 billion for expanding manufacturing capacity and $500 million for R&D investment. This initiative aims to bolster domestic biotech manufacturing, create high-paying jobs, and reinforce the U.S. healthcare supply chain.

ニュース